Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-024642

Director acquired 2,409 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ASELAGE STEVE Director 2020-08-31 Grant or award +2,409 $4.15 $9,997 28,613 D
Loading xslF345X03/form4.xml…